Jump Financial LLC Reduces Stock Holdings in Cabot Co. (NYSE:CBT)

Jump Financial LLC cut its holdings in shares of Cabot Co. (NYSE:CBT - Free Report) by 58.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,655 shares of the specialty chemicals company's stock after selling 3,685 shares during the period. Jump Financial LLC's holdings in Cabot were worth $242,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. R Squared Ltd acquired a new stake in Cabot during the 4th quarter worth $26,000. EverSource Wealth Advisors LLC boosted its stake in shares of Cabot by 37.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock worth $74,000 after buying an additional 219 shares during the period. GAMMA Investing LLC boosted its stake in shares of Cabot by 10.7% during the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock worth $123,000 after buying an additional 130 shares during the period. Manchester Capital Management LLC increased its position in Cabot by 1,685.1% in the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock valued at $153,000 after acquiring an additional 1,584 shares during the period. Finally, KBC Group NV increased its position in Cabot by 43.1% in the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock valued at $187,000 after acquiring an additional 616 shares during the period. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Price Performance

Shares of CBT traded up $0.91 during mid-day trading on Friday, hitting $78.13. The company's stock had a trading volume of 106,629 shares, compared to its average volume of 393,114. The firm has a 50-day simple moving average of $81.33 and a 200 day simple moving average of $92.88. Cabot Co. has a 1-year low of $73.63 and a 1-year high of $117.46. The firm has a market capitalization of $4.24 billion, a P/E ratio of 10.38, a P/E/G ratio of 0.74 and a beta of 1.04. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72.

Cabot (NYSE:CBT - Get Free Report) last issued its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Analysts predict that Cabot Co. will post 7.57 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CBT. StockNews.com upgraded Cabot from a "hold" rating to a "buy" rating in a research note on Thursday, April 17th. UBS Group lowered their price objective on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research report on Monday, April 7th. JPMorgan Chase & Co. cut their price objective on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research report on Friday, February 21st. Finally, Mizuho lowered their target price on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a report on Tuesday, January 7th.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.